EUVIMEDEUVIMED entdecken
Crossref

Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders

The Journal of Allergy and Clinical Immunology: In Practice · 2026-07 · 14 (7) · 1489-1490

DOI: 10.1016/j.jaip.2026.06.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-07.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders. The Journal of Allergy and Clinical Immunology: In Practice, 14(7), 1489-1490. https://doi.org/10.1016/j.jaip.2026.06.004

Vancouver

Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(7):1489-1490. doi:10.1016/j.jaip.2026.06.004

BibTeX
@article{euvimed2026,
  title = {Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  volume = {14},
  number = {7},
  pages = {1489--1490},
  doi = {10.1016/j.jaip.2026.06.004}
}
Kostenlos starten →